IBO Key Statistics, Chart & Performance
The current stock price of IBO is 0.5462 USD. In the past month the price increased by 3.03%.
IBO Latest News, Press Relases and Analysis
IBO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.94 | 1.02T | ||
| JNJ | JOHNSON & JOHNSON | 19.94 | 498.62B | ||
| MRK | MERCK & CO. INC. | 12 | 262.45B | ||
| PFE | PFIZER INC | 7.79 | 141.77B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.23 | 109.91B | ||
| ZTS | ZOETIS INC | 19.95 | 55.75B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.49 | 22.50B | ||
| VTRS | VIATRIS INC | 5.36 | 14.39B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.5 | 11.21B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.15 | 7.88B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.56B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.54B |
Related stock screener links
About IBO
Company Profile
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2024-09-16. The company discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. The company has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. The company also evaluates additional technologies.
Company Info
IMPACT BIOMEDICAL INC
1400 Broadfield Blvd., Suite 130
Houston TEXAS US
Employees: 2
Phone: 15852321500
IMPACT BIOMEDICAL INC / IBO FAQ
Can you describe the business of IMPACT BIOMEDICAL INC?
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2024-09-16. The company discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. The company has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. The company also evaluates additional technologies.
What is the stock price of IMPACT BIOMEDICAL INC today?
The current stock price of IBO is 0.5462 USD. The price increased by 18.87% in the last trading session.
Does IBO stock pay dividends?
IBO does not pay a dividend.
How is the ChartMill rating for IMPACT BIOMEDICAL INC?
IBO has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Which stock exchange lists IBO stock?
IBO stock is listed on the NYSE Arca exchange.
Can you provide the sector and industry classification for IMPACT BIOMEDICAL INC?
IMPACT BIOMEDICAL INC (IBO) operates in the Health Care sector and the Pharmaceuticals industry.
Should I buy IBO stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IBO.
IBO Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to IBO.
IBO Financial Highlights
Over the last trailing twelve months IBO reported a non-GAAP Earnings per Share(EPS) of -3.58. The EPS decreased by -509.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -201.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |